Recent articles

3 Great Stocks for Low-Risk Investors
These companies with low-risk businesses will hold up over the long run.

3 Healthcare Stocks I'd Buy Right Now
Two innovative small companies with scorching growth and one bargain biotech.

3 Absurdly Cheap Coronavirus Stocks to Buy Now
These stocks would be buys even without the pandemic.

What the COVID-19 Variants Mean for Vaccine Makers
This risk to public health is causing a strategic shift by the various developers.

Jazz Pharmaceuticals to Acquire Cannabis Drug Company
The deal to buy GW Pharmaceuticals creates a leader in neuroscience.

Johnson & Johnson Says Its One-Dose Coronavirus Vaccine Was 66% Effective in Clinical Trial
The vaccine was 100% effective in preventing hospitalization and death from COVID-19.

Could This Drug Be 100% Effective in Preventing Symptomatic COVID-19 Infections?
Strong interim trial data boosts the prospects for a treatment already worth billions.

Merck Gives Up on Coronavirus Vaccines
The company will focus on antiviral and anti-inflammatory treatments for patients infected with COVID-19.

Moderna Says Vaccine Protects Against All Known Variants
A weaker response to the South African variant prompts studies of a strain-specific booster.

Pfizer and BioNTech Report Evidence That Their Vaccine Is Effective Against COVID-19 Variant
A new study bolsters confidence in the mRNA vaccine.

Where Will Innovative Industrial Properties Be in 5 Years?
Can this profitable marijuana company keep up its winning streak?

Quidel Rapid Antigen Test for COVID-19 Wins Authorization
A new point-of-care test is both fast and accurate.

3 Top Mid-Cap Stocks to Buy Now
These companies are succeeding during the pandemic and will perform even better during a recovery.

Forget the Vaccine. Here Are the Real Reasons AstraZeneca Stock Is a Buy
The market isn't focused on the real story with this stock. That will change.

3 Top Pharma Stocks to Buy Now
Investors are shunning these stocks now, but that will change.

DexCom Has a Lot to Prove in 2021
Investors have a few questions as the company faces increasing competition.

Should You Sell Teladoc Health Stock As Coronavirus Vaccines Succeed?
Investors are worried that Teledoc Health stock will fade along with the pandemic.

Is AbbVie a Great Dividend Stock?
The stock has a high yield -- and it also has something even more important.

3 Bargain Stocks You Can Buy Today
Investors have been selling these stocks, but patient investors should take advantage of the opportunity.

This Small-Cap Stock Will Be a Long-Term Winner From the Pandemic
Wall Street seems worried that the arrival of coronavirus vaccines will take the wind out of the sails of this genetic and medical testing company. That view misses the big picture.